z-logo
open-access-imgOpen Access
Evaluation of Etest Strips for Rapid Susceptibility Testing of Mycobacterium tuberculosis
Author(s) -
I. M. Freixo,
Paulo Caldas,
Fátima Martins,
Rossana Coimbra Brito,
Rosa Maria Carvalho Ferreira,
Leila S. Fonseca,
Maria Helena Féres Saad
Publication year - 2002
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.40.6.2282-2284.2002
Subject(s) - etest , mycobacterium tuberculosis , tuberculosis , isoniazid , microbiology and biotechnology , mycobacterium tuberculosis complex , biology , streptomycin , medicine , antibiotics , pathology
In this study, our objective was to evaluate Etest strips containing exponential gradients of isoniazid (INH), rifampin (RIF), and streptomycin (STR) for susceptibility testing of Mycobacterium tuberculosis. M. tuberculosis isolates were tested for antimicrobial susceptibilities by the standard proportion method using Löwenstein-Jensen (LJ) medium and by the Etest. The MICs determined by the Etest were obtained at 5, 7, or 10 days. In some strains with Etest-discrepant results, radiometric susceptibility testing (BACTEC) was performed to determine a consensus result. M. tuberculosis concordance between the two methods was 97% (86 of 89 isolates) for RIF, 96% for INH (84 of 87 isolates), and 80% (61 of 76 isolates) for STR. Most of the MICs determined by the Etest were easy to interpret and readable within 5 days. Results correlated well with those obtained by the LJ proportion and BACTEC methods for INH and RIF. However, a high proportion of false-sensitive and false-resistant results were observed, most often for STR. We also observed that variations in the inoculum size of M. tuberculosis isolates affected the MICs to a substantial degree. These discrepancies, along with the expense of the media, the Etest strips, and the specialized equipment required (CO2 incubator), make this method less useful in developing countries.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here